Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Arora

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Transplantation and Cellular Therapy|June 5, 2024
The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical OutcomesShivjot Singh, Qing Cao, Connor Demorest, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2015
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling DonorsAleksandr Lazaryan, Daniel J Weisdorf, Todd DeFor, et al.
Blood Advances|August 30, 2021
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk modelRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Blood|June 22, 2006
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor StudyChristopher J Fraser, Smita Bhatia, Kirsten Ness, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2018
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell TransplantationLivia Hegerova, Adam Bachan, Qing Cao, et al.
American Journal of Hematology|June 15, 2017
Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipientsHewan Belete, Linda J Burns, Ryan Shanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2015
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood TransplantationNelli Bejanyan, John Rogosheske, Todd DeFor, et al.
European Journal of Haematology|October 21, 2020
Weight-based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantationNelli Bejanyan, John Rogosheske, Qing Cao, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
American Journal of Epidemiology|May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Transplantation and Cellular Therapy|June 5, 2024
The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical OutcomesShivjot Singh, Qing Cao, Connor Demorest, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2015
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling DonorsAleksandr Lazaryan, Daniel J Weisdorf, Todd DeFor, et al.
Blood Advances|August 30, 2021
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk modelRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Blood|June 22, 2006
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor StudyChristopher J Fraser, Smita Bhatia, Kirsten Ness, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2018
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell TransplantationLivia Hegerova, Adam Bachan, Qing Cao, et al.
American Journal of Hematology|June 15, 2017
Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipientsHewan Belete, Linda J Burns, Ryan Shanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2015
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood TransplantationNelli Bejanyan, John Rogosheske, Todd DeFor, et al.
European Journal of Haematology|October 21, 2020
Weight-based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantationNelli Bejanyan, John Rogosheske, Qing Cao, et al.
Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.
American Journal of Epidemiology|May 5, 2017
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F Krakow, Michael Hemmer, Tao Wang, et al.
Pageof 17